|
莱苞迪甙 C
|
R304233-50mg
|
≥96% |
63550-99-2 |
50mg
|
¥ 181.9
|
现货 |
|
0 |
阿拉丁 |
|
莱苞迪甙 C
|
R304233-10mg
|
≥96% |
63550-99-2 |
10mg
|
¥ 68.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-3-羟基丁酸
|
R304188-5g
|
≥95% |
625-72-9 |
5g
|
¥ 198.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-3-羟基丁酸
|
R304188-1g
|
≥95% |
625-72-9 |
1g
|
¥ 62.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-3-羟基丁酸
|
R304188-250mg
|
≥95% |
625-72-9 |
250mg
|
¥ 30.9
|
现货 |
|
0 |
阿拉丁 |
|
利福喷丁
|
R304143-5g
|
Moligand™, ≥97% |
61379-65-5 |
5g
|
¥ 566.9
|
现货 |
|
0 |
阿拉丁 |
|
利福喷丁
|
R304143-1g
|
Moligand™, ≥97% |
61379-65-5 |
1g
|
¥ 230.9
|
现货 |
|
0 |
阿拉丁 |
|
间苯二酚四苯基二磷酸酯
|
R304040-2.5kg
|
|
57583-54-7 |
2.5kg
|
¥ 3075.9
|
现货 |
|
0 |
阿拉丁 |
|
间苯二酚四苯基二磷酸酯
|
R304040-500g
|
|
57583-54-7 |
500g
|
¥ 1053.9
|
现货 |
|
0 |
阿拉丁 |
|
间苯二酚四苯基二磷酸酯
|
R304040-100g
|
|
57583-54-7 |
100g
|
¥ 304.9
|
现货 |
|
0 |
阿拉丁 |
|
间苯二酚四苯基二磷酸酯
|
R304040-25g
|
|
57583-54-7 |
25g
|
¥ 110.9
|
现货 |
|
0 |
阿拉丁 |
|
间苯二酚四苯基二磷酸酯
|
R304040-5g
|
|
57583-54-7 |
5g
|
¥ 43.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-(-)-2-氯-1-苯乙醇
|
R304018-25g
|
≥98% |
56751-12-3 |
25g
|
¥ 893.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-(-)-2-氯-1-苯乙醇
|
R304018-5g
|
≥98% |
56751-12-3 |
5g
|
¥ 339.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-(-)-2-氯-1-苯乙醇
|
R304018-1g
|
≥98% |
56751-12-3 |
1g
|
¥ 84.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-(+)-2-乙酰氧基丙酰氯
|
R303922-200mg
|
≥98% |
53636-19-4 |
200mg
|
¥ 358.9
|
现货 |
|
0 |
阿拉丁 |
|
D-脱硫生物素
|
R303913-1g
|
≥95% |
533-48-2 |
1g
|
¥ 1225.9
|
现货 |
|
0 |
阿拉丁 |
|
D-脱硫生物素
|
R303913-250mg
|
≥95% |
533-48-2 |
250mg
|
¥ 438.9
|
现货 |
|
0 |
阿拉丁 |
|
甲基-2,3-O-异亚丙基-beta-D-呋喃核糖苷
|
R303676-25g
|
≥95% |
4099-85-8 |
25g
|
¥ 1215.9
|
现货 |
|
0 |
阿拉丁 |
|
甲基-2,3-O-异亚丙基-beta-D-呋喃核糖苷
|
R303676-5g
|
≥95% |
4099-85-8 |
5g
|
¥ 281.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
甲基-2,3-O-异亚丙基-beta-D-呋喃核糖苷
|
R303676-1g
|
≥95% |
4099-85-8 |
1g
|
¥ 54.9
|
现货 |
|
0 |
阿拉丁 |
|
甲基-2,3-O-异亚丙基-beta-D-呋喃核糖苷
|
R303676-250mg
|
≥95% |
4099-85-8 |
250mg
|
¥ 41.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-2-氯丙-1-醇
|
R303592-1g
|
≥95% |
37493-14-4 |
1g
|
¥ 127.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-2-氯丙-1-醇
|
R303592-250mg
|
≥95% |
37493-14-4 |
250mg
|
¥ 43.9
|
期货,请咨询 |
|
0 |
阿拉丁 |